Extracorporeal photopheresis (ECP) for chronic graft versus host disease (cGVHD)

This page provides information on changes to the MBS item descriptors for extracorporeal photopheresis treatments for chronic graft versus host disease (cGVHD) patients from 1 July 2023.

Page last updated: 15 June 2023

From 1 July 2023, the descriptors for MBS items 13761 (initial ECP treatment) and 13762 (continuing ECP treatment) will be amended in line with the clinical intent of the original application supported by MSAC. The amendment changes the claiming frequency of the items from ‘applicable once per treatment cycle’ to ‘applicable once per treatment session’.


PDF version Extracorporeal Photopheresis {ECP} for Chronic Graft Versus Host Disease {cGVHD} (PDF 156 KB)
Word version Extracorporeal Photopheresis {ECP} for Chronic Graft Versus Host Disease {cGVHD} (Word 125 KB)

In this section